COVID-19 INFECTIONS IN SARCOIDOSIS: A PROSPECTIVE SINGLE CENTER STUDY OF 886 SARCOIDOSIS PATIENTS

Sarcoidosis patients, especially those receiving immunosuppressive therapy (1), may have an increased risk for opportunistic infections including fungal infections and mycobacteria (1-3). Recent reports have suggested an increased rate of coronavirus disease 2019 (COVID-19) infection in sarcoidosis patients (4-7). These studies were usually retrospective and/or self-reported cases. We report the results of a prospective study performed in our sarcoidosis clinic comparing the rate of COVID-19 infection in sarcoidosis to cancer patients.